AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in endometrial cancer
Approval covers import and marketing of Imfinzi for use with chemotherapy in first-line treatment
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.